Real‐life second‐line epirubicin–paclitaxel regimen as treatment of relapsed small‐cell lung cancer: EpiTax study

por Annic, Josselin, Babey, Hélène, Corre, Romain, Descourt, Renaud, Quéré, Gilles, Renaud, Emmanuelle, Lambert, Mickaël, Le Noac'h, Pierre, Dhamelincourt, Estelle, Nguyen, Jessica, Vu, Alicia, Bourbonne, Vincent, Robinet, Gilles, Geier, Margaux
Publicado 2022